The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Antiemetic Drugs Market Research Report 2024
Synopsis
An antiemetic drug is a drug that is effective against vomiting and nausea. Antiemetics are typically used to treat motion sickness and the side effects of opioid analgesics, general anaesthetics, antipsychotic medication and chemotherapy directed against cancer.
The global Antiemetic Drugs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The adoption of inorganic growth strategies including M&As, partnerships, and regional acquisition, result in improved market penetration of the vendors. Technological advancements result in improvement and expansion of the product portfolio and R&D advancements. Collaborations or acquisitions of the regional players or the complete acquisition of products will contribute to the growth of the antiemetic drug market as it expands the geographical presence of the acquiring vendor.
This report aims to provide a comprehensive presentation of the global market for Antiemetic Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Antiemetic Drugs.
Report Scope
The Antiemetic Drugs market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Antiemetic Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Antiemetic Drugs manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
GlaxoSmithKline
Johnson & Johnson
Pfizer
Sanofi
Abbott
Bristol-Myers Squibb
Cipla
Eisai
Eli Lilly
Glenmark
Helsinn Healthcare
Heron Therapeutics
IPCA Laboratories
Lupin
Merck
Novartis
RedHill
Sun Pharmaceutical Industries
Takeda Pharmaceutical
Segment by Type
Dopamine Antagonist
5-HT-3 Receptor Antagonist
NK1 Receptor Antagonist
Cannabinoid Receptor Antagonist
Segment by Application
Chemotherapy
Gastroenteritis
Surgery
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Antiemetic Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Antiemetic Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
An antiemetic drug is a drug that is effective against vomiting and nausea. Antiemetics are typically used to treat motion sickness and the side effects of opioid analgesics, general anaesthetics, antipsychotic medication and chemotherapy directed against cancer.
The global Antiemetic Drugs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The adoption of inorganic growth strategies including M&As, partnerships, and regional acquisition, result in improved market penetration of the vendors. Technological advancements result in improvement and expansion of the product portfolio and R&D advancements. Collaborations or acquisitions of the regional players or the complete acquisition of products will contribute to the growth of the antiemetic drug market as it expands the geographical presence of the acquiring vendor.
This report aims to provide a comprehensive presentation of the global market for Antiemetic Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Antiemetic Drugs.
Report Scope
The Antiemetic Drugs market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Antiemetic Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Antiemetic Drugs manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
GlaxoSmithKline
Johnson & Johnson
Pfizer
Sanofi
Abbott
Bristol-Myers Squibb
Cipla
Eisai
Eli Lilly
Glenmark
Helsinn Healthcare
Heron Therapeutics
IPCA Laboratories
Lupin
Merck
Novartis
RedHill
Sun Pharmaceutical Industries
Takeda Pharmaceutical
Segment by Type
Dopamine Antagonist
5-HT-3 Receptor Antagonist
NK1 Receptor Antagonist
Cannabinoid Receptor Antagonist
Segment by Application
Chemotherapy
Gastroenteritis
Surgery
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Antiemetic Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Antiemetic Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Antiemetic Drugs Market Overview
1.1 Product Overview and Scope of Antiemetic Drugs
1.2 Antiemetic Drugs Segment by Type
1.2.1 Global Antiemetic Drugs Market Value Comparison by Type (2024-2030)
1.2.2 Dopamine Antagonist
1.2.3 5-HT-3 Receptor Antagonist
1.2.4 NK1 Receptor Antagonist
1.2.5 Cannabinoid Receptor Antagonist
1.3 Antiemetic Drugs Segment by Application
1.3.1 Global Antiemetic Drugs Market Value by Application: (2024-2030)
1.3.2 Chemotherapy
1.3.3 Gastroenteritis
1.3.4 Surgery
1.4 Global Antiemetic Drugs Market Size Estimates and Forecasts
1.4.1 Global Antiemetic Drugs Revenue 2019-2030
1.4.2 Global Antiemetic Drugs Sales 2019-2030
1.4.3 Global Antiemetic Drugs Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Antiemetic Drugs Market Competition by Manufacturers
2.1 Global Antiemetic Drugs Sales Market Share by Manufacturers (2019-2024)
2.2 Global Antiemetic Drugs Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Antiemetic Drugs Average Price by Manufacturers (2019-2024)
2.4 Global Antiemetic Drugs Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Antiemetic Drugs, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Antiemetic Drugs, Product Type & Application
2.7 Antiemetic Drugs Market Competitive Situation and Trends
2.7.1 Antiemetic Drugs Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Antiemetic Drugs Players Market Share by Revenue
2.7.3 Global Antiemetic Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Antiemetic Drugs Retrospective Market Scenario by Region
3.1 Global Antiemetic Drugs Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Antiemetic Drugs Global Antiemetic Drugs Sales by Region: 2019-2030
3.2.1 Global Antiemetic Drugs Sales by Region: 2019-2024
3.2.2 Global Antiemetic Drugs Sales by Region: 2025-2030
3.3 Global Antiemetic Drugs Global Antiemetic Drugs Revenue by Region: 2019-2030
3.3.1 Global Antiemetic Drugs Revenue by Region: 2019-2024
3.3.2 Global Antiemetic Drugs Revenue by Region: 2025-2030
3.4 North America Antiemetic Drugs Market Facts & Figures by Country
3.4.1 North America Antiemetic Drugs Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Antiemetic Drugs Sales by Country (2019-2030)
3.4.3 North America Antiemetic Drugs Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Antiemetic Drugs Market Facts & Figures by Country
3.5.1 Europe Antiemetic Drugs Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Antiemetic Drugs Sales by Country (2019-2030)
3.5.3 Europe Antiemetic Drugs Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Antiemetic Drugs Market Facts & Figures by Country
3.6.1 Asia Pacific Antiemetic Drugs Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Antiemetic Drugs Sales by Country (2019-2030)
3.6.3 Asia Pacific Antiemetic Drugs Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Antiemetic Drugs Market Facts & Figures by Country
3.7.1 Latin America Antiemetic Drugs Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Antiemetic Drugs Sales by Country (2019-2030)
3.7.3 Latin America Antiemetic Drugs Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Antiemetic Drugs Market Facts & Figures by Country
3.8.1 Middle East and Africa Antiemetic Drugs Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Antiemetic Drugs Sales by Country (2019-2030)
3.8.3 Middle East and Africa Antiemetic Drugs Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Antiemetic Drugs Sales by Type (2019-2030)
4.1.1 Global Antiemetic Drugs Sales by Type (2019-2024)
4.1.2 Global Antiemetic Drugs Sales by Type (2025-2030)
4.1.3 Global Antiemetic Drugs Sales Market Share by Type (2019-2030)
4.2 Global Antiemetic Drugs Revenue by Type (2019-2030)
4.2.1 Global Antiemetic Drugs Revenue by Type (2019-2024)
4.2.2 Global Antiemetic Drugs Revenue by Type (2025-2030)
4.2.3 Global Antiemetic Drugs Revenue Market Share by Type (2019-2030)
4.3 Global Antiemetic Drugs Price by Type (2019-2030)
5 Segment by Application
5.1 Global Antiemetic Drugs Sales by Application (2019-2030)
5.1.1 Global Antiemetic Drugs Sales by Application (2019-2024)
5.1.2 Global Antiemetic Drugs Sales by Application (2025-2030)
5.1.3 Global Antiemetic Drugs Sales Market Share by Application (2019-2030)
5.2 Global Antiemetic Drugs Revenue by Application (2019-2030)
5.2.1 Global Antiemetic Drugs Revenue by Application (2019-2024)
5.2.2 Global Antiemetic Drugs Revenue by Application (2025-2030)
5.2.3 Global Antiemetic Drugs Revenue Market Share by Application (2019-2030)
5.3 Global Antiemetic Drugs Price by Application (2019-2030)
6 Key Companies Profiled
6.1 GlaxoSmithKline
6.1.1 GlaxoSmithKline Corporation Information
6.1.2 GlaxoSmithKline Description and Business Overview
6.1.3 GlaxoSmithKline Antiemetic Drugs Sales, Revenue and Gross Margin (2019-2024)
6.1.4 GlaxoSmithKline Antiemetic Drugs Product Portfolio
6.1.5 GlaxoSmithKline Recent Developments/Updates
6.2 Johnson & Johnson
6.2.1 Johnson & Johnson Corporation Information
6.2.2 Johnson & Johnson Description and Business Overview
6.2.3 Johnson & Johnson Antiemetic Drugs Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Johnson & Johnson Antiemetic Drugs Product Portfolio
6.2.5 Johnson & Johnson Recent Developments/Updates
6.3 Pfizer
6.3.1 Pfizer Corporation Information
6.3.2 Pfizer Description and Business Overview
6.3.3 Pfizer Antiemetic Drugs Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Pfizer Antiemetic Drugs Product Portfolio
6.3.5 Pfizer Recent Developments/Updates
6.4 Sanofi
6.4.1 Sanofi Corporation Information
6.4.2 Sanofi Description and Business Overview
6.4.3 Sanofi Antiemetic Drugs Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Sanofi Antiemetic Drugs Product Portfolio
6.4.5 Sanofi Recent Developments/Updates
6.5 Abbott
6.5.1 Abbott Corporation Information
6.5.2 Abbott Description and Business Overview
6.5.3 Abbott Antiemetic Drugs Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Abbott Antiemetic Drugs Product Portfolio
6.5.5 Abbott Recent Developments/Updates
6.6 Bristol-Myers Squibb
6.6.1 Bristol-Myers Squibb Corporation Information
6.6.2 Bristol-Myers Squibb Description and Business Overview
6.6.3 Bristol-Myers Squibb Antiemetic Drugs Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Bristol-Myers Squibb Antiemetic Drugs Product Portfolio
6.6.5 Bristol-Myers Squibb Recent Developments/Updates
6.7 Cipla
6.6.1 Cipla Corporation Information
6.6.2 Cipla Description and Business Overview
6.6.3 Cipla Antiemetic Drugs Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Cipla Antiemetic Drugs Product Portfolio
6.7.5 Cipla Recent Developments/Updates
6.8 Eisai
6.8.1 Eisai Corporation Information
6.8.2 Eisai Description and Business Overview
6.8.3 Eisai Antiemetic Drugs Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Eisai Antiemetic Drugs Product Portfolio
6.8.5 Eisai Recent Developments/Updates
6.9 Eli Lilly
6.9.1 Eli Lilly Corporation Information
6.9.2 Eli Lilly Description and Business Overview
6.9.3 Eli Lilly Antiemetic Drugs Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Eli Lilly Antiemetic Drugs Product Portfolio
6.9.5 Eli Lilly Recent Developments/Updates
6.10 Glenmark
6.10.1 Glenmark Corporation Information
6.10.2 Glenmark Description and Business Overview
6.10.3 Glenmark Antiemetic Drugs Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Glenmark Antiemetic Drugs Product Portfolio
6.10.5 Glenmark Recent Developments/Updates
6.11 Helsinn Healthcare
6.11.1 Helsinn Healthcare Corporation Information
6.11.2 Helsinn Healthcare Antiemetic Drugs Description and Business Overview
6.11.3 Helsinn Healthcare Antiemetic Drugs Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Helsinn Healthcare Antiemetic Drugs Product Portfolio
6.11.5 Helsinn Healthcare Recent Developments/Updates
6.12 Heron Therapeutics
6.12.1 Heron Therapeutics Corporation Information
6.12.2 Heron Therapeutics Antiemetic Drugs Description and Business Overview
6.12.3 Heron Therapeutics Antiemetic Drugs Sales, Revenue and Gross Margin (2019-2024)
6.12.4 Heron Therapeutics Antiemetic Drugs Product Portfolio
6.12.5 Heron Therapeutics Recent Developments/Updates
6.13 IPCA Laboratories
6.13.1 IPCA Laboratories Corporation Information
6.13.2 IPCA Laboratories Antiemetic Drugs Description and Business Overview
6.13.3 IPCA Laboratories Antiemetic Drugs Sales, Revenue and Gross Margin (2019-2024)
6.13.4 IPCA Laboratories Antiemetic Drugs Product Portfolio
6.13.5 IPCA Laboratories Recent Developments/Updates
6.14 Lupin
6.14.1 Lupin Corporation Information
6.14.2 Lupin Antiemetic Drugs Description and Business Overview
6.14.3 Lupin Antiemetic Drugs Sales, Revenue and Gross Margin (2019-2024)
6.14.4 Lupin Antiemetic Drugs Product Portfolio
6.14.5 Lupin Recent Developments/Updates
6.15 Merck
6.15.1 Merck Corporation Information
6.15.2 Merck Antiemetic Drugs Description and Business Overview
6.15.3 Merck Antiemetic Drugs Sales, Revenue and Gross Margin (2019-2024)
6.15.4 Merck Antiemetic Drugs Product Portfolio
6.15.5 Merck Recent Developments/Updates
6.16 Novartis
6.16.1 Novartis Corporation Information
6.16.2 Novartis Antiemetic Drugs Description and Business Overview
6.16.3 Novartis Antiemetic Drugs Sales, Revenue and Gross Margin (2019-2024)
6.16.4 Novartis Antiemetic Drugs Product Portfolio
6.16.5 Novartis Recent Developments/Updates
6.17 RedHill
6.17.1 RedHill Corporation Information
6.17.2 RedHill Antiemetic Drugs Description and Business Overview
6.17.3 RedHill Antiemetic Drugs Sales, Revenue and Gross Margin (2019-2024)
6.17.4 RedHill Antiemetic Drugs Product Portfolio
6.17.5 RedHill Recent Developments/Updates
6.18 Sun Pharmaceutical Industries
6.18.1 Sun Pharmaceutical Industries Corporation Information
6.18.2 Sun Pharmaceutical Industries Antiemetic Drugs Description and Business Overview
6.18.3 Sun Pharmaceutical Industries Antiemetic Drugs Sales, Revenue and Gross Margin (2019-2024)
6.18.4 Sun Pharmaceutical Industries Antiemetic Drugs Product Portfolio
6.18.5 Sun Pharmaceutical Industries Recent Developments/Updates
6.19 Takeda Pharmaceutical
6.19.1 Takeda Pharmaceutical Corporation Information
6.19.2 Takeda Pharmaceutical Antiemetic Drugs Description and Business Overview
6.19.3 Takeda Pharmaceutical Antiemetic Drugs Sales, Revenue and Gross Margin (2019-2024)
6.19.4 Takeda Pharmaceutical Antiemetic Drugs Product Portfolio
6.19.5 Takeda Pharmaceutical Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Antiemetic Drugs Industry Chain Analysis
7.2 Antiemetic Drugs Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Antiemetic Drugs Production Mode & Process
7.4 Antiemetic Drugs Sales and Marketing
7.4.1 Antiemetic Drugs Sales Channels
7.4.2 Antiemetic Drugs Distributors
7.5 Antiemetic Drugs Customers
8 Antiemetic Drugs Market Dynamics
8.1 Antiemetic Drugs Industry Trends
8.2 Antiemetic Drugs Market Drivers
8.3 Antiemetic Drugs Market Challenges
8.4 Antiemetic Drugs Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
